Too True to be Bad

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Too True to be Bad

Psychology journals rarely publish nonsignificant results. At the same time, it is often very unlikely (or “too good to be true”) that a set of studies yields exclusively significant results. Here, we use likelihood ratios to explain when sets of studies that contain a mix of significant and nonsignificant results are likely to be true or “too true to be bad.” As we show, mixed results are not ...

متن کامل

LCZ696: too good to be true?

This issue of the European Heart Journal contains a major statement by the PARADIGM-HF Investigators, who present an ‘putative placebo’ analysis for LCZ696, a new medicine that yielded a remarkable reduction in total mortality and heart failure events in patients with significant heart failure with reduced ejection fraction (HF-REF). (NB: I serve as a consultant on Novartis’s cardiovascular–met...

متن کامل

Too Odd (Not) to Be True? A Reply to Olsson

In ‘Corroborating Testimony, Probability and Surprise’, Erik J. Olsson ascribes to L. Jonathan Cohen the claims that if two witnesses provide us with the same information, then the less probable the information is, the more confident we may be that the information is true (C), and the stronger the information is corroborated (C*). We question whether Cohen intends anything like claims (C) and (...

متن کامل

Too Good to Be True: Asset Pricing Implications of Pessimism∗

We evaluate whether the introduction of pessimistic homogeneous beliefs in the frictionless Lucas-Mehra-Prescott model and the Kehoe-Levine-Alvarez-Jermann model with endogenous borrowing constraints, helps explain the equity premium, the risk-free rate and the equity volatility puzzles as well as the short-term momentum and long-term reversal of excess returns. We calibrate the model to U.S. d...

متن کامل

Novel oral anticoagulants: too good to be true?

It is fair to say that the pharmacological therapy of cardiovascular disease has not been an area of spectacular growth in recent years. Little has happened in the treatment of hypertension and heart failure. There has been interest in the development of antiplatelet drugs in acute coronary syndromes and percutaneous interventions, but not in long-term cardiovascular prevention to compete with ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Social Psychological and Personality Science

سال: 2017

ISSN: 1948-5506,1948-5514

DOI: 10.1177/1948550617693058